See more : Real Matters Inc. (RLLMF) Income Statement Analysis – Financial Results
Complete financial analysis of China Shineway Pharmaceutical Group Limited (CSWYY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Shineway Pharmaceutical Group Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Jy Gas Limited (1407.HK) Income Statement Analysis – Financial Results
- Chinasoft International Limited (0354.HK) Income Statement Analysis – Financial Results
- Industrial Logistics Properties Trust (ILPT) Income Statement Analysis – Financial Results
- Aceso Life Science Group Limited (0474.HK) Income Statement Analysis – Financial Results
- JPMorgan UK Smaller Companies Investment Trust Plc (JMI.L) Income Statement Analysis – Financial Results
China Shineway Pharmaceutical Group Limited (CSWYY)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.shineway.com
About China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.52B | 3.95B | 3.22B | 2.66B | 2.71B | 2.57B | 1.92B | 1.99B | 2.05B | 2.23B | 2.19B | 2.13B | 1.98B | 2.04B | 1.63B | 1.28B | 1.01B | 841.48M | 831.38M | 703.58M | 604.04M |
| Cost of Revenue | 1.12B | 1.01B | 813.21M | 667.86M | 724.43M | 694.15M | 652.52M | 706.88M | 693.89M | 751.20M | 712.69M | 740.30M | 682.46M | 603.37M | 455.13M | 360.86M | 274.85M | 249.18M | 274.77M | 252.00M | 315.00M |
| Gross Profit | 3.39B | 2.94B | 2.41B | 1.99B | 1.98B | 1.88B | 1.27B | 1.29B | 1.36B | 1.48B | 1.47B | 1.39B | 1.30B | 1.44B | 1.18B | 914.32M | 738.04M | 592.30M | 556.61M | 451.58M | 289.04M |
| Gross Profit Ratio | 75.15% | 74.38% | 74.77% | 74.85% | 73.23% | 72.99% | 66.01% | 64.54% | 66.23% | 66.30% | 67.41% | 65.28% | 65.61% | 70.40% | 72.13% | 71.70% | 72.86% | 70.39% | 66.95% | 64.18% | 47.85% |
| Research & Development | 110.46M | 117.45M | 112.71M | 99.71M | 102.72M | 128.13M | 96.51M | 73.59M | 68.93M | 80.42M | 83.29M | 68.05M | 57.39M | 21.87M | 33.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 326.50M | 279.80M | 256.56M | 273.36M | 275.66M | 256.27M | 247.29M | 277.65M | 302.31M | 285.40M | 262.02M | 252.76M | 229.24M | 196.67M | 136.07M | 99.90M | 80.93M | 67.72M | 71.46M | 55.12M | 34.73M |
| Selling & Marketing | 1.98B | 1.82B | 1.50B | 1.19B | 1.13B | 997.35M | 515.22M | 370.65M | 375.49M | 411.66M | 439.14M | 423.26M | 255.40M | 350.13M | 353.20M | 276.34M | 258.08M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.31B | 2.11B | 1.76B | 1.47B | 1.40B | 1.25B | 762.51M | 648.30M | 677.80M | 697.06M | 701.16M | 676.02M | 484.64M | 546.80M | 489.27M | 376.24M | 339.01M | 67.72M | 71.46M | 55.12M | 34.73M |
| Other Expenses | 0.00 | 104.98M | 82.85M | 86.17M | 86.15M | 38.77M | 4.75M | 4.74M | 8.52M | 5.75M | 1.58M | 268.00K | -189.45M | 2.31M | 46.15M | 32.70M | 207.24M | 46.30M | 18.21M | 859.00K | 805.00K |
| Operating Expenses | 2.42B | 2.12B | 1.79B | 1.71B | 1.46B | 1.34B | 780.82M | 691.82M | 661.10M | 727.11M | 700.89M | 668.05M | 352.58M | 491.18M | 340.22M | 470.80M | 369.34M | 251.57M | 232.36M | 171.63M | 104.76M |
| Cost & Expenses | 3.38B | 3.13B | 2.61B | 2.38B | 2.18B | 2.03B | 1.43B | 1.40B | 1.35B | 1.48B | 1.41B | 1.41B | 1.04B | 1.09B | 795.35M | 831.67M | 644.19M | 500.74M | 507.14M | 423.63M | 419.77M |
| Interest Income | 95.21M | 98.47M | 102.89M | 116.06M | 116.81M | 133.45M | 101.55M | 100.58M | 97.35M | 112.84M | 86.11M | 31.55M | 41.11M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.74M | 630.00K | 1.25M | 16.60M | 2.66M | 0.00 | 0.00 | 0.00 | 61.00K | 16.86M | 3.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.50M | 40.22M |
| Depreciation & Amortization | 177.10M | 185.86M | 182.39M | 208.41M | 204.98M | 201.99M | 199.08M | 195.12M | 162.44M | 144.32M | 98.06M | 82.00M | 65.68M | 53.03M | 45.33M | 36.04M | 32.08M | 29.73M | 25.79M | 22.28M | 21.96M |
| EBITDA | 1.42B | 1.10B | 903.74M | 620.04M | 672.71M | 691.76M | 602.71M | 778.67M | 776.63M | 844.85M | 788.03M | 757.45M | 1.02B | 1.04B | 883.20M | 479.56M | 400.78M | 370.47M | 350.04M | 302.23M | 206.23M |
| EBITDA Ratio | 31.44% | 22.48% | 21.87% | 23.42% | 24.86% | 26.91% | 31.40% | 37.91% | 37.80% | 37.90% | 36.03% | 35.52% | 51.15% | 48.90% | 54.08% | 37.61% | 39.57% | 44.03% | 42.10% | 42.96% | 34.14% |
| Operating Income | 975.54M | 713.58M | 534.37M | 422.40M | 476.48M | 494.30M | 408.07M | 564.60M | 614.19M | 700.52M | 689.97M | 675.45M | 949.50M | 943.83M | 837.87M | 443.51M | 368.70M | 340.73M | 324.24M | 279.95M | 184.28M |
| Operating Income Ratio | 21.60% | 18.06% | 16.58% | 15.91% | 17.61% | 19.23% | 21.26% | 28.32% | 29.89% | 31.42% | 31.55% | 31.68% | 47.84% | 46.30% | 51.30% | 34.78% | 36.40% | 40.49% | 39.00% | 39.79% | 30.51% |
| Total Other Income/Expenses | 264.72M | 203.45M | 185.74M | -27.37M | 166.29M | 174.83M | 179.75M | 106.96M | 99.20M | 108.05M | 84.10M | 75.84M | 0.00 | 47.98M | 46.15M | 32.70M | 207.24M | 46.30M | 18.21M | 859.00K | 805.00K |
| Income Before Tax | 1.24B | 917.03M | 720.10M | 395.02M | 642.77M | 669.13M | 587.82M | 695.25M | 797.17M | 863.74M | 859.65M | 799.74M | 949.50M | 991.81M | 884.02M | 476.21M | 575.94M | 387.03M | 342.45M | 280.81M | 185.08M |
| Income Before Tax Ratio | 27.46% | 23.21% | 22.34% | 14.87% | 23.75% | 26.03% | 30.62% | 34.88% | 38.80% | 38.75% | 39.31% | 37.51% | 47.84% | 48.66% | 54.13% | 37.34% | 56.86% | 45.99% | 41.19% | 39.91% | 30.64% |
| Income Tax Expense | 270.74M | 194.25M | 163.43M | 99.99M | 139.62M | 163.25M | 136.27M | 106.06M | 139.45M | 159.05M | 176.00M | 152.08M | 193.92M | 170.05M | 116.71M | 77.97M | 85.30M | 54.06M | 5.45M | 10.66M | -7.31M |
| Net Income | 969.51M | 722.77M | 556.67M | 295.03M | 503.15M | 505.88M | 451.55M | 589.20M | 657.91M | 704.78M | 683.65M | 647.70M | 755.60M | 821.76M | 767.30M | 398.24M | 490.64M | 332.98M | 337.01M | 260.79M | 151.37M |
| Net Income Ratio | 21.47% | 18.30% | 17.27% | 11.11% | 18.59% | 19.68% | 23.52% | 29.56% | 32.02% | 31.62% | 31.26% | 30.38% | 38.07% | 40.31% | 46.98% | 31.23% | 48.44% | 39.57% | 40.54% | 37.07% | 25.06% |
| EPS | 1.28 | 19.20 | 14.80 | 7.80 | 12.80 | 12.40 | 11.00 | 14.20 | 16.00 | 17.00 | 16.60 | 15.60 | 18.20 | 19.80 | 18.60 | 9.60 | 11.80 | 8.00 | 8.00 | 8.40 | 5.00 |
| EPS Diluted | 1.28 | 19.20 | 14.80 | 7.80 | 12.80 | 12.40 | 11.00 | 14.20 | 16.00 | 17.00 | 16.60 | 15.60 | 18.20 | 19.80 | 18.60 | 9.60 | 11.80 | 8.00 | 8.00 | 8.40 | 5.00 |
| Weighted Avg Shares Out | 757.43M | 37.77M | 37.76M | 37.82M | 39.04M | 40.82M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.43M | 31.05M | 30.27M |
| Weighted Avg Shares Out (Dil) | 755.40M | 37.77M | 37.76M | 37.84M | 39.05M | 40.89M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.35M | 41.43M | 31.05M | 30.27M |
Source: https://incomestatements.info
Category: Stock Reports